Cochlear Limited
CHEOY · OTC
6/30/2025 | 12/30/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -2.60 | 0.98 | -2.34 | 1.23 |
| FCF Yield | 0.47% | 0.43% | 0.91% | 0.59% |
| EV / EBITDA | 66.30 | 61.14 | 82.80 | 63.70 |
| Quality | ||||
| ROIC | 8.42% | 9.25% | 7.51% | 9.63% |
| Gross Margin | 73.21% | 74.61% | 75.70% | 74.33% |
| Cash Conversion Ratio | 0.69 | 0.54 | 1.40 | 0.82 |
| Growth | ||||
| Revenue 3-Year CAGR | 17.43% | 16.60% | 14.66% | 9.96% |
| Free Cash Flow Growth | 11.59% | -56.85% | 67.74% | -48.02% |
| Safety | ||||
| Net Debt / EBITDA | -0.14 | -0.43 | -1.07 | -0.92 |
| Interest Coverage | 47.40 | 0.00 | 0.00 | 62.40 |
| Efficiency | ||||
| Inventory Turnover | 0.64 | 0.65 | 0.71 | 0.89 |
| Cash Conversion Cycle | 101.41 | 91.65 | 67.63 | 54.09 |